Prednisone withdrawal late after adult liver transplantation reduces diabetes, hypertension, and hypercholesterolemia without causing graft loss

Hepatology

Volumn 25, Issue 1, 1997, Pages 173-177

  Stegall, Mark D ^a   Everson, Gregory T ^a   Schroter, Gerhard ^a   Karrer, Frederick ^a   Bilir, Bahri ^a   Sternberg, Tracy ^a   Shrestha, Roshan ^a   Wachs, Michael ^a   Kam, Igal ^a  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; AZATHIOPRINE; CYCLOSPORIN; GLYCOSYLATED HEMOGLOBIN; INSULIN; METHYLPREDNISOLONE; PREDNISONE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG WITHDRAWAL; GRAFT FAILURE; GRAFT REJECTION; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; INSULIN DEPENDENT DIABETES MELLITUS; INTRAVENOUS DRUG ADMINISTRATION; LIVER FUNCTION TEST; LIVER TRANSPLANTATION; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL;

EID: 0031032623     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.510250132     Document Type: Article

References (23)

1. Belle SH, Beringer KC, Detre KM. Trends in liver transplantation in the United States. In: Teraskaki PI, Cecka JM, eds. Clinical Transplants 1993. Los Angeles: UCLA Tissue Typing Laboratory, 1994:19-35.
2. Abu-Elmagd K, Todo S, Fung J, Demetris J, Rakela J, Rao AS, Iwatsuki S, et al. Hepatic transplantation at the University of Pittsburgh: New horizons and paradigms after 30 years of experience. In: Teraskaki PI, Cecka JM, eds. Clinical Transplants 1994. Los Angeles: UCLA Tissue Typing Laboratory, 1995:133-156.
3. Klintmalm GB, Nery JR, Husberg BS, Gonwa TA, Tillery GW. Rejection in liver transplantation. HEPATOLOGY 1989;10:978-985.
4. Stegall MD, Everson G, Schroter G, Bilir B, Karrer F, Kam I. Metabolic complications after liver transplantation: diabetes, hypercholesterolemia, hypertension and obesity. Transplantation 1995;60:1057-1060.
5. Dunn SP, Falkenstein K, Lawrence JP, Meyers R, Vincur CD, Billmire DF, Weintraub WH. Monotherapy with cyclosporine for chronic immunosuppression in pediatric liver transplant recipients. Transplantation 1994; 57:544-547.
6. Andrews WS, Shimaoka S, Sommerauer J, Moore P, Hudgins P. Steroid withdrawal after pediatric liver transplantation. Transplant Proc 1994; 26:159-160.
7. Margarit C, Martinez-Ibanez V, Tormo R, Infante D, Iglesias H. Maintenance immunosuppression without steroids in pediatric liver transplantation. Transplant Proc 1989;21:2230-2231.
8. Padbury RT, Gunson BK, Dousset B, Hubscher SG, Buckels JAC, Neuberger JM, Elias E, et al. Steroid withdrawal from long-term immunosuppression in liver allograft recipients. Transplantation 1993;55:789-794.
9. McDiarmid SV, Farmer D, Goldstein LI, Martin P, Vargas J, Tipton JR, Simmons F, et al. A randomized prospective trial of steroid withdrawal after liver transplantation. Transplantation 1995;60:1443-1450.
10. Mor E, Gonwa TA, Husberg BS, Goldstein RM, Klintmalm GB. Late-onset acute rejection in orthotopic liver transplantation - associated risk factors and outcome. Transplantation 1992;54:821-824.
11. Stratta RJ, Armbrust MJ, Oh CS, Pirsch JD, Kalayoglu M, Sollinger HW, Belzer FO. Withdrawal of steroid immunosuppression in renal transplant recipients. Transplantation 1988;45:323-328.
12. Hricik DE, O'Toole MA, Schulak JA, Herson J. Steroid-free immunosuppression in cyclosprorine-treated renal transplant recipients: a meta-analysis. J Am Soc Nephrol 1993;4:1300-1305.
13. Ratcliffe PJ, Firth JC, Higgins RM, Smith D, Gray DW, Morris PJ. Randomized controlled trial of complete steroid withdrawal in renal transplant recipients receiving triple immunosuppression. Transplant Proc 1993;25: 590.
14. Hricit DE, Whalen CC, Lautman J, Bartucci MR, Moir EJ, Mayes JH, Schulak JA. Withdrawal of steroids after renal transplantation - clinical predictors of outcome. Transplantation 1992;53:41-45.
15. Sinclair NR. Low-dose steroid therapy in cyclosporine-treated recipients with well-functioning grafts. The Canadian Multicentre Transplant Study Group. Can Med Assoc J 1992;147:645-651.
16. Kobashigawa JA, Stevenson LW, Brownfield ED, Morigucki JC, Kawata N, Randrich R, Drinkwater DC, et al. Initial success of steroid weaning late after heart transplantation. J Heart Lung Transplant 1992;11:428-431.
17. Miller LW, Wolford T, McBride LR, Peigh P, Pennington DG. Successful withdrawal of corticosteroids in heart transplantation. J Heart Lung Transplant 1992;11:431-434.
18. Robertson RP. Cyclosporine-induced inhibition of insulin secretion in isolated rat islets and HIT cells. Diabetes 1986;35:1016-1021.
19. Roth D, Milgrom M, Esquenazi V, Fuller L, Burke G, Miller J. Post-transplant hyperglycemia: increased incidence in cyclosporine-treated renal allograft recipients. Transplantation 1989;47:278-281.
20. Hricick DE, Bartucci MR, Moir EJ, Mayes JT, Schulak JA. Effects of steroid withdrawal on posttransplant diabetes mellitus in cyclosporine-treated renal transplant recipients. Transplantation 1991;51:374-377.
21. Bennett WM, Porter GA. Cyclosporine-associated hypertension. Am J Med 1988;85:131-133.
22. Hricick DE, Lautman J, Bartucci MR, Moir EJ, Mayes JT, Schuk JA. Variable effects of steroid withdrawal on blood pressure reduction ion cyclosporine-treated renal transplant recipients. Transplantation 1992;53: 1232-1235.
23. Hricick DE, Bartucci MR, Mayes JT, Schulak JA. The effects of steroid withdrawal on the lipoprotein profiles of cyclosporine-treated kidney and kidney-pancreas transplant recipients. Transplantation 1992;54:868-871.